Mar 07, 2017 09:00 am UTC| Business
MAINZ, Germany, March 07, 2017 -- BioNTech AG, a fully-integrated biotechnology company pioneering individualized cancer immunotherapy, today announced that it will present interim data from an ongoing Phase I/II...
Allergy Partners Provides Tips About Dry, Itchy Winter Skin
Mar 07, 2017 09:00 am UTC| Business
DALLAS, March 07, 2017 -- Do you have dry, itchy skin in the winter? Well, believe it or not, this may not be due to an allergy. “Winter itch” is the term given to the sensation of itching that many people develop...
HyperSolar Releases Video Demonstration of Renewable Hydrogen Production
Mar 07, 2017 08:45 am UTC| Business
SANTA BARBARA, Calif., March 07, 2017 -- HyperSolar, Inc. (OTCQB:HYSR), the developer of a breakthrough technology to produce renewable hydrogen using sunlight and any source of water, today released a video...
ADVA Optical Networking SE: Oscilloquartz Synchronizes Orange Egypt's National Network
Mar 07, 2017 08:01 am UTC| Business
Complete Timing Solution Enables Next-Generation LTE Services Cairo, Egypt. March 7, 2017. Oscilloquartz, an ADVA Optical Networking company, today announced that Orange Egypt has deployed its OSA 5421 as part of a...
Correlsense Partners with AASHDIT Technologies to Strengthen its International Presence in India
Mar 07, 2017 07:57 am UTC| Business
TEL AVIV, Israel, March 07, 2017 -- Correlsense, the leading enterprise application performance management (APM) company recognized in Gartner’s Magic Quadrant for APM Suites 2016, recently announced a new strategic...
Sodexo : Sodexo announces changes to the Group Executive Committee
Mar 07, 2017 07:42 am UTC| Business
Sodexo announces changes to the Group Executive Committee Paris, March 7, 2017 - Sodexo, world leader in Quality of Life services, announces the following changes to the Group Executive Committee: Debbie...
Mar 07, 2017 07:40 am UTC| Business
NANOBIOTIX TO PRESENT PRECLINICAL DATA ON NANOPARTICLE RADIOENHANCER NBTXR3 AT THE AACR ANNUAL MEETING 2017 Antitumor efficacy of NBTXR3 in different types of tumors - in vivo preclinical data ...